Type 1 diabetes-related autoantibodies are rare in Alaska native populations

References

• Ali O, Tan TT, Sakinah O, Khalid BA, Wu LL, Ng ML. Prevalence of NIDDM and impaired glucose tolerance in aborigines and Malays in Malaysia and their relationship to sociodemographic, health, and nutritional factors. Diabetes Care 1993; 16: 68–75.
   PubMed Web of Science ®Google Scholar
• Burrows NR, Geiss LS, Engelgau MM, Acton KJ. Prevalence of diabetes among native Americans and Alaska natives, 1990–1997. Diabetes Care 2000; 23: 1786-1790.
   Google Scholar
• Christie MR, Roll U, Payton MA, Hatfield EC, Ziegler AG. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care 1997; 20: 965–970.
   Google Scholar
• Dabelea D, Palmer JP Bennett PH, Pettitt DJ, Knowler WC. Absence of glutamic acid decarboxylase antibodies in Pima Indian children with diabetes mellitus. Diabetologia 1999; 42: 1265–1266.
   Web of Science ®Google Scholar
• Diabetes mellitus. Report of a WHO studygroup. World Health Organ Tech Rep Ser 1985; 727.
   Google Scholar
• Dowse GK, Spark RA, Mayo B, et al. Extraordinary prevalence of non-insulin-dependent diabetes mellitus and bimodal plasma glucose distribution in the Wanigela people of Papua New Guinea. Med J Aust 1994; 160: 767–774.
   PubMed Web of Science ®Google Scholar
• Ebbesson SO, Schraer CD, Risica PM, et al. Diabetes and impaired glucose tolerance in three Alaskan Eskimo populations. The Alaska-Siberia Project. Diabetes Care 1998; 21: 563–569.
   Web of Science ®Google Scholar
• Ebbesson SO, Kennish J, Ebbesson L, Go O, Yeh J. Diabetes is related to fatty acid imbalance in Eskimos. Int J Circumpolar Health 1999; 58: 108–119.
   Google Scholar
• Fukui M, Nakano K, Shigeta H, et al. Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapy. Diabet Med 1997; 14: 148–152.
   Web of Science ®Google Scholar
• Gianani R, Rabin DU, Verge CF, et al. ICA512 autoantibody radioassay. Diabetes 1995;44: 1340–1344.
   PubMed Web of Science ®Google Scholar
• Gottsater A, Landin-Olsson M, Lernmark A, Fernlund P, Sundkvist G. Islet cell antibodies are associated with beta-cell failure also in obese adult onset diabetic patients. Acta Diabetol 1994; 31: 226–231.
   PubMed Web of Science ®Google Scholar
• Hagopian WA, Karlsen AE, Gottsater A, et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 1993; 91: 368–374.
   PubMed Web of Science ®Google Scholar
• Kanungo A, Shtauvere A, Samal KC, Tripathy BB, Falorni A, Sanjeevi, CB. Antibodies to ICA512 and GAD65 in patients with non-insulin-dependent diabetes (NIDDM) from Eastern India. Diabetologia 1997; 40: A164.
   Google Scholar
• Kasuga A, Maruyama T, Ozawa Y, et al. Antibody to the Mr 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes in Japanese. J Autoimmun 1996; 9: 105–111.
   PubMed Web of Science ®Google Scholar
• Knowler WC, Bennett PH, Bottazzo GF, Diniach D. Islet cell antibodies and diabetes mellitus in Pima Indians. Diabetologia 1979; 17: 161–164.
   PubMed Web of Science ®Google Scholar
• Knowler WC, Pettitt DJ, Bennett PH, Williams RC. Diabetes mellitus in the Pima Indians: genetic and evolutionary considerations. Am J Phys Anthropol 1983; 62: 107–114.
   PubMed Web of Science ®Google Scholar
• Leslie RD, Pozzilli P. Type I diabetes masquer-ading as type II diabetes. Possible implications for prevention and treatment. Diabetes Care 1994; 17: 1214–1219.
   Google Scholar
• Littorin B, Sundkvist G, Hagopian W, et al. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes. Diabetes Care 1999; 22: 409–412.
   Google Scholar
• Mouratoff GJ, Carroll NV, Scott EM. Diabetes mellitus in Eskimos. Jama 1967; 199: 107–112.
   Google Scholar
• Mouratoff GJ, Carroll NV, Scott EM. Diabetes mellitus in Athabascan Indians in Alaska. Diabetes 1969; 18: 29–32.
   Google Scholar
• Murphy NJ, Schraer CD, Bulkow LR, Boyko EJ, Lanier, AP. Diabetes mellitus in Alaskan Yup’ik Eskimos and Athabascan Indians after 25 yr. Diabetes Care 1992; 15: 1390–1392.
   Web of Science ®Google Scholar
• Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MI. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. Diabetes Care 1995; 18: 1557–1565.
   Google Scholar
• Pozzilli P DeMario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care 2001; 24: 1460–1467.
   PubMed Web of Science ®Google Scholar
• Ravussin E, Valencia ME, Esparza J, Bennett PH, Schulz, LO. Effects of a traditional lifestyle on obesity in Pima Indians. Diabetes Care 1994; 17: 1067–1074.
   PubMed Web of Science ®Google Scholar
• Report on the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183–1197.
   Google Scholar
• Risica PM, Ebbesson SOE, Schraer CD, Nobmann ED, Caballero BH. Body fat distribution in Alaskan Eskimos of the Bering Straits region: The Alaskan Siberia project. Int J Obes 2000; 24: 171–179.
   Google Scholar
• Rolandsson O, Hagg E, Hampe C, et al. Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index. Diabetologia 1999; 42: 555–559.
   Web of Science ®Google Scholar
• Sanjeevi CB, Kanungo A, Shtauvere A, Samal KC, Tripathi, BB. Association of HLA class II alleles with different subgroups of diabetes mellitus in Eastern India identify different associations with IDDM and malnutrition-related diabetes. Tissue Antigens 1999; 54: 83–87.
   PubMed Web of Science ®Google Scholar
• Schraer CD, Ebbesson SO, Boyko E, Nobmann E, Adler A, Cohen J. Hypertension and diabetes among SiberianYup’ik Eskimos of St. Lawrence Island, Alaska. Public Health Rep 1996; 111: 51–52.
   Web of Science ®Google Scholar
• Schraer CD, Adler AT, Mayer AM, Halderson KR, Trimble BA. Diabetes complications and mortality among Alaska Natives: 8 years of observation. Diabetes Care 1997; 20: 314–321.
   Google Scholar
• Schraer CD, Ebbesson SO, Adler AT, Cohen JS, Boyko EJ, Nobmann ED. Glucose tolerance and insulin resistance syndrome among St. Lawrence Island Eskimos. Int J Circumpolar Health 1998; 57: 348–354.
   Google Scholar
• Schraer CD, Risica PM, Ebbesson SO, Go OT, Howard BV, Mayer AM. Low fasting insulin levels in Eskimos compared to American Indians: are Eskimos less insulin resistant? Int J Circumpolar Health 1999; 58: 272–280.
   Google Scholar
• Schranz DB, Bekris L, Landin O-M, et al. A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS). J Immunol Methods 1998; 213: 87–97.
   Google Scholar
• Sellers E, Eisenbarth G, Young TK, Dean HJ. Diabetes-associated autoantibodies in aboriginal children. Lancet 2000; 355: 1156.
   Google Scholar
• Shields GF, Schmiechen AM, Frazier BL, et al. mtDNA sequences suggest a recent evolutionary divergence for Beringian and northern North American populations. Am J Hum Genet 1993; 53: 549–562.
   PubMed Web of Science ®Google Scholar
• Starikovskaya YB, Sukernik RI, Schurr TG, Kogelnik AM, Wallace DC. mtDNA diversity in Chukchi and Siberian Eskimos: implications for the genetic history of ancient Beringia and the peopling of the New World. Am J Hum Genet 1998; 63: 1473–1491.
   Google Scholar
• Tuomi T, Carlsson A, Li H, et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999; 48: 150–157.
   PubMed Web of Science ®Google Scholar
• Turner R, Stratton I, Horton V, et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997; 350: 1288–1293.
   PubMed Web of Science ®Google Scholar
• Wroblewski M, Gottsater A, Lindgarde F, Fernlund P, Sundkvist, G. Gender, autoanti-bodies, and obesity in newly diagnosed diabetic patients aged 40–75 years. Diabetes Care 1998; 21: 250–255.
   Google Scholar
• Zimmet P, Turner R, McCarty D, Rowley M, Mackay, I. Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diabetes Care 1999; 22: B59–B64.
   Web of Science ®Google Scholar